Blue Jay Capital Management adds Mead Johnson Nutrition CO (MJN) to its portfolio

Mead Johnson Nutrition CO (MJN) : Blue Jay Capital Management added new position in Mead Johnson Nutrition CO during the most recent quarter end. The investment management firm now holds 166,370 shares of Mead Johnson Nutrition CO which is valued at $13.9 Million , the company said in a statement filed on May 13, 2016 with the SEC.Mead Johnson Nutrition CO makes up approximately 8.66% of Blue Jay Capital Management’s portfolio.

Other Hedge Funds, Including , Intact Investment Management added MJN to its portfolio by purchasing 3,000 company shares during the most recent quarter which is valued at $251,130. Mead Johnson Nutrition CO makes up approx 0.01% of Intact Investment Management’s portfolio.Shell Asset Management Co boosted its stake in MJN in the latest quarter, The investment management firm added 25,111 additional shares and now holds a total of 67,696 shares of Mead Johnson Nutrition CO which is valued at $5.7 Million. Mead Johnson Nutrition CO makes up approx 0.14% of Shell Asset Management Co’s portfolio. Coconut Grove Bank sold out all of its stake in MJN during the most recent quarter. The investment firm sold 1,237 shares of MJN which is valued $103,549.Isthmus Partners boosted its stake in MJN in the latest quarter, The investment management firm added 5,393 additional shares and now holds a total of 45,096 shares of Mead Johnson Nutrition CO which is valued at $3.8 Million. Mead Johnson Nutrition CO makes up approx 1.25% of Isthmus Partners’s portfolio.Cadence Capital Management reduced its stake in MJN by selling 34 shares or 0.92% in the most recent quarter. The Hedge Fund company now holds 3,653 shares of MJN which is valued at $310,688. Mead Johnson Nutrition CO makes up approx 0.02% of Cadence Capital Management’s portfolio.

Mead Johnson Nutrition CO opened for trading at $82.78 and hit $83.2 on the upside on Wednesday, eventually ending the session at $82.8, with a gain of 0.41% or 0.34 points. The heightened volatility saw the trading volume jump to 8,95,237 shares. Company has a market cap of $15,456 M.

On the company’s financial health, Mead Johnson Nutrition CO reported $0.87 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $0.84. The company had revenue of $962.10 million for the quarter, compared to analysts expectations of $954.99 million. The company’s revenue was down -12.1 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.09 EPS.

Many Wall Street Analysts have commented on Mead Johnson Nutrition CO. Mead Johnson Nutrition CO was Upgraded by Credit Suisse to ” Outperform” on Mar 16, 2016.

Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures distributes and sells infant formulas children’s nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas children’s milks and milk modifiers dietary supplements for pregnant and breastfeeding mothers pediatric vitamins and products for pediatric metabolic disorders. The Company operates through three segments: Asia Latin America and North America/Europe. The Company’s Enfa family of brands including Enfamil infant formula is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers healthcare professionals and retailers in more than 50 countries in Asia North America Latin America and Europe.

Leave a Reply

Mead Johnson Nutrition CO - Is it time to Sell?

Top Brokerage Firms are advising their investors on Mead Johnson Nutrition CO. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.